ARCHIVES

ODAC Unanimously Rejects Melblez, Citing Lower Survival

This article is from The Cancer Letter archive.

Vol. 39 No. 20 | May 17, 2013

Download PDF Visit The Full Archive

Related Articles

Adjuvant Chemotherapy Unneeded In Children with Low-Risk Disease

March 29, 2013

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

February 24, 2006

Jako Bows Out with Blast At NCI, Calls For IOM Review Of Cancer Program

April 15, 1988

Paulette Gray named director of NCI Division of Extramural Activities.

April 22, 2005

House Medicare Reform Bill Takes A smaller Bite In Drug Reimbursement

June 20, 1997

AACI Remains Split On Guidelines; Terry Proposes 25 Percent Limit On Staff Investigator Salaries

January 30, 1981